Terry Day to Carcinoma, Squamous Cell
This is a "connection" page, showing publications Terry Day has written about Carcinoma, Squamous Cell.
Connection Strength
9.230
-
Trismus intra-operative release and expansion (TIRE): A novel operative treatment for trismus. Head Neck. 2023 03; 45(3):578-585.
Score: 0.570
-
Elective neck dissection in salivary gland malignancies: Systematic review and meta-analysis. Head Neck. 2022 02; 44(2):505-517.
Score: 0.530
-
Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis. Target Oncol. 2021 11; 16(6):743-752.
Score: 0.526
-
Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients. Am J Otolaryngol. 2019 Jan - Feb; 40(1):40-45.
Score: 0.423
-
Preoperative predictors of occult nodal disease in cT1N0 oral cavity squamous cell carcinoma: Review of 2623 cases. Head Neck. 2018 09; 40(9):1967-1976.
Score: 0.414
-
Hypermetabolic Vocal Cord Focus With Recurrent Oral Cancer History. JAMA Oncol. 2018 Feb 01; 4(2):248-249.
Score: 0.406
-
Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659.
Score: 0.403
-
Predictors of contralateral-bilateral nodal disease in oropharyngeal cancer: A National Cancer Data Base Study. Head Neck. 2018 02; 40(2):338-348.
Score: 0.397
-
Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Cancer. 2017 Dec 15; 123(24):4841-4850.
Score: 0.394
-
Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017 Jul 15; 123(14):2651-2660.
Score: 0.381
-
Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base. Cancer. 2017 Jun 15; 123(12):2248-2257.
Score: 0.380
-
Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 May; 140(5):441-7.
Score: 0.313
-
A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 Apr; 140(4):331-7.
Score: 0.311
-
The association between T-stage and clinical nodal metastasis In HPV-positive oropharyngeal cancer. Am J Otolaryngol. 2014 Jul-Aug; 35(4):463-8.
Score: 0.305
-
Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis. Oral Oncol. 2014 Feb; 50(2):77-83.
Score: 0.302
-
mTOR inhibitors and its role in the treatment of head and neck squamous cell carcinoma. Curr Treat Options Oncol. 2012 Mar; 13(1):71-81.
Score: 0.269
-
Autocrine motility-stimulatory pathways of oral premalignant lesion cells. Clin Exp Metastasis. 2007; 24(2):131-9.
Score: 0.191
-
Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):28-31.
Score: 0.188
-
Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma. Cancer Immunol Immunother. 2007 Jul; 56(7):1077-86.
Score: 0.187
-
Assessing oral cancer knowledge among dental students in South Carolina. J Am Dent Assoc. 2005 Mar; 136(3):373-8.
Score: 0.166
-
Oral cancer and precancerous lesions. CA Cancer J Clin. 2002 Jul-Aug; 52(4):195-215.
Score: 0.138
-
Systematic review of neuroendocrine carcinomas of the oropharynx. Head Neck. 2022 07; 44(7):1725-1736.
Score: 0.136
-
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
Score: 0.131
-
Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
Score: 0.126
-
Prognostic factors associated with achieving total oral diet after glossectomy with microvascular free tissue transfer reconstruction. Oral Oncol. 2019 05; 92:59-66.
Score: 0.110
-
Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use. Otolaryngol Head Neck Surg. 2019 05; 160(5):855-861.
Score: 0.108
-
Double paddle ulnar perforator free flap in reconstruction of through-and-through and fistulous defects of the head and neck. Laryngoscope. 2017 06; 127(6):1302-1305.
Score: 0.094
-
Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1068-74.
Score: 0.086
-
Oral cavity and oropharyngeal squamous cell carcinoma--an update. CA Cancer J Clin. 2015 Sep-Oct; 65(5):401-21.
Score: 0.085
-
Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma. J Hematol Oncol. 2014 Sep 27; 7:65.
Score: 0.081
-
Perioperative survival of elderly head and neck squamous cell carcinoma patients. Laryngoscope. 2014 Oct; 124(10):2281-6.
Score: 0.080
-
Adjunctive diagnostic techniques for oral lesions of unknown malignant potential: Systematic review with meta-analysis. Head Neck. 2015 May; 37(5):755-62.
Score: 0.078
-
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
Score: 0.065
-
Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Hum Immunol. 2010 Jul; 71(7):659-65.
Score: 0.059
-
Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions. Hum Immunol. 2009 Jun; 70(6):375-82.
Score: 0.055
-
1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells. Otolaryngol Head Neck Surg. 2009 Feb; 140(2):235-40.
Score: 0.054
-
Human papillomavirus and head and neck cancer: a growing concern. J S C Med Assoc. 2008 Dec; 104(8):247-51.
Score: 0.054
-
Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1313-8.
Score: 0.053
-
Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008 Jul; 118(7):1180-5.
Score: 0.052
-
Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer. Dermatol Surg. 2008 Apr; 34(4):483-97.
Score: 0.051
-
Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett. 2007 Oct 18; 256(1):101-11.
Score: 0.049
-
Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma. Curr Treat Options Oncol. 2007 Jun; 8(3):227-38.
Score: 0.048
-
Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma. Cancer Lett. 2007 Apr 18; 248(2):269-79.
Score: 0.046
-
IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun. 2006 Apr 14; 342(3):851-8.
Score: 0.044
-
The use of temporal polyethylene implant after temporalis myofascial flap transposition: clinical and radiographic results from its use in 21 patients. J Oral Maxillofac Surg. 2006 Jan; 64(1):12-22.
Score: 0.044
-
Laryngeal penetration and aspiration during swallowing after the treatment of advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg. 2005 Jul; 131(7):615-9.
Score: 0.042
-
Prevention of head and neck cancer. Curr Oncol Rep. 2005 Mar; 7(2):145-53.
Score: 0.041
-
Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg. 2005 Jan; 132(1):55-62.
Score: 0.041
-
Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Biol Chem. 2004 Oct 22; 279(43):44311-9.
Score: 0.040
-
Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope. 2004 Aug; 114(8):1362-7.
Score: 0.040
-
Free Flap Inset Techniques in Salvage Laryngopharyngectomy Repair: Impact on Fistula Formation and Function. Laryngoscope. 2021 03; 131(3):E875-E881.
Score: 0.030
-
Role of mitomycin in upper digestive tract stricture. Head Neck. 2007 Jan; 29(1):12-7.
Score: 0.012